Mesenchymal stem cells (MSCs) are invaluable cell sources for understanding stem cell biology and potential application in tissue engineering and regenerative medicine. The current issues of MSCs that demand to be further addressed are limited donors, tissue sources and limited capacity of ex vivo expansion. Here, we describe a simple and easy protocol for generating functional mesenchymal stem cells from human pluripotent stem cells (hPSCs) via one-step low glucose medium switch strategy in feeder-free culture system. In this protocol, human induced pluripotent stem cells (hiPSCs) and H9 human embryonic stem cells (hESCs) were successfully differentiated into MSCs, named hiPSC-MSCs and hESC-MSCs, respectively. The derived hiPSC-MSCs and hESC-MSCs exhibited common MSC characteristics as MSCs derived from human bone marrow (hBM-MSCs), including expressing MSC surface markers and possessing capability of tri-lineage differentiation in vitro (adipogenesis, osteogenesis and chondrogenesis). As compared with other available protocols, our protocol can be applied to generate a large number of MSCs from hPSCs with high efficiency, low-cost manner, moreover, not involving embryoid body, mouse feeder-cell, flow sorting, and pathway inhibitors (such as SB203580 and SB431542). We believe that this protocol could provide a robust platform to reach the future demand for producing the industrial scale of MSC from hPSCs for autologous cell-based therapy. Keywords: Mesenchymal stem cells (MSCs), Human pluripotent stem cells (hPSCs), Human induced pluripotent stem cells (hiPSCs), Human embryonic stem cells (hESCs), Differentiation, Mesenchymal stem cells derived from induced pluripotent stem cells (hiPSC-MSCs), Mesenchymal stem cells derived from human embryonic stem cells (hESC-MSCs), Regenerative medicine [Background] Mesenchymal stem cells (MSCs) are adult stem cell populations derived from postnatal tissues. They retain fast proliferation rate, self-renewal capabilities, and lineage-specific differentiation potential. Moreover, MSCs are capable of producing growth factors, having anti-apoptosis properties, lacking carcinogenicity (Trounson and McDonald, 2015) , and no adverse effects noted thus far in clinical trials (Lalu et al., 2012) . Therefore, MSCs represent promising cell candidates for stem
Procedure
A. Thawing and recovering human iPSCs or human ESCs (hiPSCs/hESCs) (6-well plate format) 1. Pre-warm a required volume of TeSR-E8 medium to room temperature in a 50 ml Falcon tube (see Note 1).
2. Prepare an appropriate quantity of Vitronectin XF coated 6-well plates at least 1 h before cell thawing (see Recipes).
3. Remove the cryogenic vial of frozen hiPSCs/hESCs from liquid nitrogen quickly and immerse the vial into a 37 °C water bath. 4 . Hold the cap to constantly swirl cryogenic vial without submerging the cap. 5 . When most cells are thawed/only a few ice crystals remain, take the cryogenic vial out of the water bath, spray the cryogenic vial with 70% ethanol and move the vial into biosafety culture cabinet. 6 . Open the cap, and then gently transfer the cell suspension into a 15 ml Falcon tube containing TeSR-E8 medium prepared before (see Note 2). 7 . Rinse the cryogenic vial with 1 ml TeSR-E8 medium and add the solution into the same Falcon tube, gently mix cells by pipetting. 8 . Centrifuge at 300 x g for 5 min at room temperature, and then discard the supernatant. 9 . Resuspend the hiPSC/hESC pellets with 2 ml TeSR-E8 medium by gently pipetting up and down several times. 10 . Add 20 μl ROCK inhibitor (100x, stock solution) to the cell suspension for increasing survival of hPSCs (see Note 3). 11 . Discard the excess Vitronectin XF from the pre-coated 6-well plate, and slowly transfer hiPSC/hESCs suspension into the plate. One cryogenic vial of hiPSC/hESC can be plated into 1-2 wells of the 6-well plate.
12. Gently move the culture plate back and forth, left and right motions several times to disperse cells across the whole well (see Note 4) . 13 . Place the plate in a 37 °C, 5% CO2 incubator and culture overnight.
14. The next day, replace the medium with fresh TeSR-E8 medium without Rock inhibitor Y-27632. 15 . After that, feed cells daily with 2 ml TeSR-E8 medium per well in the 6-well plate, the hiPSCs/hESCs are allowed to grow for 4-5 days. When cells reach 70%-80% confluence, they can be passaged (see Note 5) .
B. Passage hiPSCs and hESCs using ReLeSR (6-well plate format) Generally, hiPSCs and hESCs can grow as colonies when plated on Vitronectin XF, with typical undifferentiated, dense and compact morphology and a high nucleus-to-cytoplasm ratio ( Figure 1B , Day -2). Ideally, hiPSCs and hESCs can be passaged every 4-5 days (70%-80% confluence) as either single cell or cell aggregates. We routinely use ReLeSR for maintenance of hiPSCs and hESCs as cell aggregates (see Note 6).
Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC. 7 www.bio-protocol.org/e3080 Vol 8, Iss 22, Nov 20, 2018 DOI:10.21769/BioProtoc.3080 The following steps are for passaging hiPSCs/hESCs from wells of the 6-well plate in TeSR-E8 medium and Vitronectin XF systems. If using other culture vessels, adjust volumes of reagents according to surface area (see Table 1 ). We use a simple and efficient protocol to differentiate hiPSCs and hESCs into MSCs in feeder-free culture system. The timetable diagram of this differentiation procedure is shown in Figure 1A . glucose medium into culture wells and continue to culture cells at 37 °C, 5% CO2 (see Note 13).
c. Observe cells under microscope to check cell morphology changes and record the photos (see Note 14) ( Figure 1B h. Stain cells with 2% Alizarin Red S for calcium deposit identification ( Figure 3A) , and then acquires images using standard light microscopy. e. Place the plates back into the 37 °C, 5% CO2 incubator for 2 h micromass cultivation.
Chondrogenic differentiation of hiPSC-MSCs and hESC-MSCs
f. After micromass cultivating, supplement 100 μl the chondrogenesis medium to culture wells.
g. Incubate the cells in the 37 °C, 5% CO2 incubator for 3 weeks and feed cultures every 3 days with the chondrogenic differentiation medium.
h. Paraffin embed chondrogenic pellets, section, and dye cells by toluidine blue staining to evaluate extracellular chondrocyte matrix ( Figure 3B ), and then acquire images using standard light microscopy. the hiPSCs/hESCs should be ready for passaging.
Adipogenic differentiation of hiPSC-MSCs and hESC-MSCs

Enzymes such as collagenase IV or dispase does not work well with hPSCs cultured in
TeSR-E8 medium system. ReLeSR is an enzyme-free reagent suitable for dissociating hiPSCs and hESCs into cell clumps for routine passaging without manual removal of differentiated regions.
7. The treatment time of ReLeSR may vary depending on the hPSC lines and quality of colonies.
The optimal dissociation time with ReLeSR for some certain hPSC lines may take longer than 5 min. 9. The split ratio can vary for different hPSC lines. The established hPSC cultures can be split with the ratio of 1:6 to 1:12 (i.e., cell clumps from one well can be plated into six to twelve wells). 10 . Uneven distribution of cell slumps may increase the differentiation of hiPSC/hESCs. Avoid disturbing the plate for overnight to attach cells maximally.
11. It is normal to see some cell debris the day after passaging. When hiPSCs/hESCs reach 80% confluence, they can be passaged or frozen down with TeSR-E8 Freezing Medium. Do not allow hiPSC/hESCs to be over-confluent to avoid spontaneous differentiation.
12.
The hiPSCs/hESCs should be at least 40% confluent 2 days after seeding. If the cells are not enough to initialize differentiation, the cells can be incubated for 1 or 2 more days before MSC differentiation. However, the hiPSCs/hESCs should not be over confluent before MSC differentiation. Otherwise, they will go through random differentiation.
13. In the first several days of hiPSC/hESC differentiation into MSCs, the differentiated cells should be washed with DPBS w/o Ca 2+ and Mg 2+ when renewing medium due to many dead cells.
Afterward, if the spent medium is clean and there are no many dead cells, the step of washing cells is unnecessary. 
